Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of Levobupivacaine After Cesarean Section

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Term pregnant patients~* American Society of Anesthesiologists physical status I or II, scheduled for elective cesarean section.~Exclusion Criteria:~* Allergy/sensitivity to the local anaesthetic~* Significant renal or liver dysfunction.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pharmacokinetics (Type: EXPERIMENTAL): A bilateral TAP block will be performed with 20 ml levobupivacaine 0,25% and epinephrine (5ug/ml). After the blockade, venous blood samples will be taken on predefined times.

Based on this trial design, predict the completion outcome and termination type (if applicable).